Method of healing skin wounds in mammals and a composition therefor
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-031/59
A61K-031/65
A61K-031/43
A61K-031/429
A61K-031/496
A61K-031/315
A61K-031/28
A61K-033/30
A61K-031/07
A61K-031/045
A61K-031/122
A61K-031/355
A61K-031/352
A61P-017/02
A61P-017/0
출원번호
US-0675729
(2003-09-30)
발명자
/ 주소
Peshoff,Mickey L.
출원인 / 주소
Peshoff,Mickey L.
인용정보
피인용 횟수 :
13인용 특허 :
2
초록▼
This invention pertains to therapeutic antibacterial/antifungal-wound healing compositions comprising a therapeutically effective amount of antibacterial agents and/or antifungal agents and/or wound healing composition alone. In one embodiment, the wound healing composition comprises (a) zinc oxide;
This invention pertains to therapeutic antibacterial/antifungal-wound healing compositions comprising a therapeutically effective amount of antibacterial agents and/or antifungal agents and/or wound healing composition alone. In one embodiment, the wound healing composition comprises (a) zinc oxide; (b) calcium channel blocker, and (c) fat-soluble vitamins admixed with antibacterial and antifungal agents. The therapeutic antibacterial/antifungal-wound healing compositions may be utilized in a wide variety of pharmaceutical products and administered orally or topically.
대표청구항▼
I claim: 1. A therapeutic tissue healing composition adapted for oral and non-oral application in mammals comprising: an effective amount of a mixture of zinc oxide, fat-soluble vitamins A, D, E, K, an effective amount of an antibacterial agent, an effective amount of an antifungal agent, and an ef
I claim: 1. A therapeutic tissue healing composition adapted for oral and non-oral application in mammals comprising: an effective amount of a mixture of zinc oxide, fat-soluble vitamins A, D, E, K, an effective amount of an antibacterial agent, an effective amount of an antifungal agent, and an effective amount of calcium channel blocker. 2. The composition of claim 1, wherein said calcium channel blocker is 3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-dimethyl ester, which has the chemical formula of C 17H18N2O6. 3. The composition of claim 1, wherein said Vitamin A is selected from the group consisting of retinol, 3,4-didehydroretinol, carotene, alpha-carotene, beta-carotene, delta-carotene, and gamma carotene. 4. The composition of claim 1, wherein said Vitamin D is selected from the group consisting of cholecalciferol and ergocalciferol. 5. The composition of claim 1, wherein said Vitamin E is selected from the group consisting of Vitamin E acetate, Vitamin E succinate, pharmaceutically acceptable Vitamin E salts and Vitamin E phosphate. 6. The composition of claim 1, wherein said antibacterial agent is selected from the group consisting of bismuth-containing compounds, sulfonamides, nitrofurans, metronidazole, nimorazole, tinidazole, benzoic acid, aminoglycosides, macrolides, penicillins, polypeptides, tetracyclines, cephalosporins, chloramphenicol, clindamycin and mixtures thereof. 7. The composition of claim 1, wherein said antibacterial agent is selected from the group consisting of bismuth aluminate, bismuth subcitrate, bismuth subgalate, bismuth subsalicylate, sulfonamides, nitrofurazone, nitrofurantoin, furazolidone, metronidazole, tinidazole, nimorazole, benzoic acid, neomycin, kynamycin, streptomycin, erythromycin, clindamycin, rifampin, rifamycin, penicillin G, penicillin V, ampicillin, amoxicillin, bacitracin, polymixin, tetracycline, chlorotetracycline, oxytetracycline, doxycycline, cephalexin, cephalothin, chloramphenicol and mixtures thereof. 8. The composition of claim 1, wherein said antibacterial agent is bacitracin zinc. 9. The composition of claim 1, wherein said antifungal agent is selected from the group consisting of astemizole, clotrimazole, omeprazole, econazole, oxiconazole, sulconazole, fluconazole, ketoconazole, itraconazole, terbinafine, and mixtures thereof. 10. The composition of claim 1, wherein said antifungal agent is clotrimazole. 11. The composition of claim 1, wherein said Vitamin A is retinyl palmitate, said Vitamin D is ergocalciferol, and said Vitamin E is tocopherol. 12. A wound healing composition for repairing human skin tissue adapted for oral and non-oral administration, comprising: a therapeutically effective mixture of zinc oxide, a calcium channel blocker, at least two fat-soluble vitamins admixed with a pharmaceutically acceptable carrier, an antibacterial agent and an antifungal agent, admixed in therapeutically effective amounts. 13. The composition of claim 12, wherein said fat-soluble vitamins comprise at least Vitamins A and D. 14. The composition of claim 13, further comprising therapeutically effective amounts of Vitamins E and K. 15. The composition of claim 14, wherein said calcium channel blocker is nifedipine. 16. The composition of claim 15, wherein the therapeutically effective mixture contains between about 0.01% and about 75% by total weight of zinc oxide, between about 0.01% and 99.99% by total weight of combined amount of fat-soluble vitamins, and between 0.0001% and 50% by total weight of nifedipine. 17. A method of healing wounds in mammals by repairing body tissue in mammals, comprising the steps of: contacting a wound to be healed with a therapeutic composition comprising an effective amount of the composition of claim 1. 18. A method of healing wounds in mammals by repairing body tissue in mammals, comprising the steps of: contacting a wound to be healed with a therapeutic composition comprising an effective amount of the composition of claim 2. 19. A method of healing wounds in mammals by repairing body tissue in mammals, comprising the steps of: contacting a wound to be healed with a therapeutic composition comprising an effective amount of the composition of claim 3. 20. A method of healing wounds in mammals by repairing body tissue in mammals, comprising the steps of: contacting a wound to be healed with a therapeutic composition comprising an effective amount of the composition of claim 4. 21. A method of healing wounds in mammals by repairing body tissue in mammals, comprising the steps of: contacting a wound to be healed with a therapeutic composition comprising an effective amount of the composition of claim 5. 22. A method of healing wounds in mammals by repairing body tissue in mammals, comprising the steps of: contacting a wound to be healed with a therapeutic composition comprising an effective amount of the composition of claim 6. 23. A method of healing wounds in mammals by repairing body tissue in mammals, comprising the steps of: contacting a wound to be healed with a therapeutic composition comprising an effective amount of the composition of claim 7. 24. A method of healing wounds in mammals by repairing body tissue in mammals, comprising the steps of: contacting a wound to be healed with a therapeutic composition comprising an effective amount of the composition of claim 8. 25. A method of healing wounds in mammals by repairing body tissue in mammals, comprising the steps of: contacting a wound to be healed with a therapeutic composition comprising an effective amount of the composition of claim 9. 26. A method of healing wounds in mammals by repairing body tissue in mammals, comprising the steps of: contacting a wound to be healed with a therapeutic composition comprising an effective amount of the composition of claim 10. 27. A method of healing wounds in mammals by repairing body tissue in mammals, comprising the steps of: contacting a wound to be healed with a therapeutic composition comprising an effective amount of the composition of claim 11. 28. A method of healing wounds in mammals by repairing body tissue in mammals, comprising the steps of: contacting a wound to be healed with a therapeutic composition comprising an effective amount of the composition of claim 12. 29. A method of healing wounds in mammals by repairing body tissue in mammals, comprising the steps of: contacting a wound to be healed with a therapeutic composition comprising an effective amount of the composition of claim 13. 30. A method of healing wounds in mammals by repairing body tissue in mammals, comprising the steps of: contacting a wound to be healed with a therapeutic composition comprising an effective amount of the composition of claim 14. 31. A method of healing wounds in mammals by repairing body tissue in mammals, comprising the steps of: contacting a wound to be healed with a therapeutic composition comprising an effective amount of the composition of claim 15. 32. A method of healing wounds in mammals by repairing body tissue in mammals, comprising the steps of: contacting a wound to be healed with a therapeutic composition comprising an effective amount of the composition of claim 16.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (2)
Michael E. McCadden, Composition for the topical treatment of poison ivy and other forms of contact dermatitis.
Van De Winkel, Jan G. J.; Van Dijk, Marcus Antonius; Halk, Edward; Gerritsen, Arnout F.; Petersen, Jørgen; Baadsgaard, Ole, Human monoclonal antibodies to epidermal growth factor receptor (EGFR).
Keller, Duane C., Periodontal device for changing a pressure in an enclosed environment about a tooth for treatment of oral biofilms associated with periodontal disease.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.